Actively Recruiting
Study of 2R,6R-Hydroxynorketamine for Treatment-Resistant Depression Using Intravenous Infusions in Adults
Led by National Institute of Mental Health (NIMH) · Updated on 2026-10-05
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying 2R,6R-hydroxynorketamine HNK, a drug that may act faster to treat symptoms of major depressive disorder MDD, a serious mental illness that can increase risks of self-harm and death. This Phase 2 randomized, double-blind, placebo-controlled crossover study evaluates HNKs ability to improve depression symptoms compared to placebo using the Montgomery-Asberg Depression Rating Scale MADRS and other mood and cognitive assessments. Participants aged 18 to 70 with treatment-resistant MDD who have completed specific screening will stop their current antidepressants and receive intravenous infusions of HNK or placebo in two separate two-week sessions. Each session involves four infusions given over two weeks with overnight stays at the clinical center. Doses start at 0.25 mgkg and may be adjusted up to 2.0 mgkg based on response and tolerability. After the first treatment period, participants have 2 to 3 weeks without study drug before crossing over to the other infusion type. During the study, participants undergo physical exams, blood tests, heart function tests, mood and cognitive evaluations, as well as optional brain imaging and brain activity scans. Researchers monitor safety through lab tests, vital signs, and adverse events. The primary measurement is the change in depression symptoms by day 12 after starting each treatment period. The study lasts several weeks with multiple assessments to evaluate mood, anxiety, suicidality, pain response, and brain biomarkers throughout the trial.
CONDITIONS
Brief Title
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
Research Team
S
Solaleh Azimipour
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here